Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
multiomics, high-throughput sequencing projects and help develop any projects based on the most advanced technologies. Your qualifications should include: Ph.D. in Biochemistry, Bioinformatics, Genomics, or a
-
$150,000. This opportunity is aimed at theoretical physicists pursuing mathematical modeling of the early universe, including its initial conditions, structure, and dynamical evolution. The award is open to
-
regulation and other aspects of cellular signal transduction. We use our structural and mechanistic insights to drive development of novel anti-cancer drugs. Systems of current interest in the lab include RAF
-
, i.e., measurements in blood that can predict individuals' cognitive development in aging and their risk of dementia. Such markers will be important for better personalizing prevention and treatment
-
development of innovative therapeutic strategies. Located in Boston and the surrounding communities, Dana-Farber Cancer Institute is a leader in life changing breakthroughs in cancer research and patient care
-
. You will be expected to contribute to ongoing research projects as well as developing independent research questions, with relevant areas including biogeography, from large geographic scales to fine
-
lung and other malignancies, affording access to patient samples and large tumor databases. Specific research areas of interest include development of optimized strategies for efficient and specific
-
creativity, and is one of six global hubs for medical device development. Through our renowned research institutes and four Colleges, we engage in cutting-edge research that transcends borders, creating a
-
Call for Outstanding Global Talents & Postdoctoral Fellows of Institute of Energy, Peking University
. The institute of energy of Peking University is oriented towards the national energy development strategy, aiming to build an international-level energy think tank and energy technology research and development
-
and underserved populations. We conduct groundbreaking research that advances treatment, we educate tomorrow's physician/researchers, and we work with amazing partners, including other Harvard Medical